Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (18)

2024

  1. Pre-exposure prophylaxis program in the Community of Madrid: Two years of experience

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Selection of initiatives to improve the management of patients with hereditary angioedema by the hospital pharmacy using the nominal group technique

    European Journal of Hospital Pharmacy

2023

  1. Achieving the UNAIDS goals by 2030 in people living with HIV: A simulation model to support the prioritization of health care interventions

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 10, pp. 589-595

  2. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  3. Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain

    PharmacoEconomics - Open, Vol. 7, Núm. 3, pp. 431-441

2022

  1. Analysis of the evolution of the price of oncology drugs after the loss of their patent and the marketing of generic medicines

    Global and Regional Health Technology Assessment, Vol. 9, pp. 68-72

  2. Business intelligence for the visualization and data analysis of Telepharmacy activity indicators in a hospital pharmacy service scorecard

    Farmacia Hospitalaria, Vol. 46, pp. 24-30

  3. Contribución de cabotegravir + rilpivirina de acción prolongada al tratamiento de la infección por VIH-1

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 4, pp. 208-214

  4. Patient Experience Evaluation of the CMO-Based Pharmaceutical Care Model vs Usual Care in People Living with HIV

    Journal of Multidisciplinary Healthcare, Vol. 15, pp. 2991-3003

2021

  1. Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 5, pp. 967-973

  2. IMPACT OF ANTIHYPERTENSIVE TREATMENT IN COVID-19 PATIENTS IN A TERTIARY CARE HOSPITAL

    European Journal of Clinical Pharmacy, Vol. 23, Núm. 4, pp. 220-225

  3. Metodología de la comparación indirecta ajustada con emparejamiento en la evaluación de fármacos hematooncológicos

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 2, pp. 55-60

2020

  1. A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study

    PharmacoEconomics - Open, Vol. 4, Núm. 4, pp. 615-624

  2. Biosimilars of monoclonal antibodies in inflammatory diseases and cancer: Current situation, challenges, and opportunities

    Farmacia Hospitalaria, Vol. 44, Núm. 3, pp. 100-108

  3. Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain

    Clinical Rheumatology, Vol. 39, Núm. 10, pp. 2919-2930

2019

  1. Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain

    ClinicoEconomics and Outcomes Research, Vol. 11, pp. 465-475

  2. Clinical pharmacy services: From cost-effectiveness analysis to a productivity indicators model

    European Journal of Hospital Pharmacy

2018

  1. Healthcare and economic impact

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, pp. 19-25